Novel targeted therapies have expanded the treatment options for patients with pediatric low-grade glioma (pLGG). In this bite-sized Booster Quiz, test your knowledge on mechanisms of action of novel targeted therapies and clinical evidence to guide treatment selection and adverse event management in pLGG. Take advantage of this opportunity to download relevant evidence and a pLGG Management Resource, featuring best practices on adverse event management!
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/applying-latest-evidence-guide-treatment-pediatric-low-grade-glioma
- Start Date: 2024-10-31 05:00:00
- End Date: 2024-10-31 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Day One Biopharmaceuticals - Amount: 33166.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest